Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse (original) (raw)
- Original Paper
- Published: 14 July 1998
Oncogene volume 17, pages 1–12 (1998)Cite this article
- 1313 Accesses
- 124 Citations
- 6 Altmetric
- Metrics details
Abstract
The yeast-derived Flp-frt site-specific DNA recombination system was used to achieve pituitary-specific inactivation of the retinoblastoma (Rb) tumor suppressor gene. Whereas mice carrying only frt sites in both alleles of Rb remain tumor free, tumorigenesis ensues when the Flp recombinase is expressed. The rate of tumorigenesis in these mice depends both on the expression level of the Flp recombinase and on the presence of frt sites in one or both Rb alleles. This permitted a more accurate definition of the consecutive steps in pituitary tumorigenesis. Our study illustrates the potential of this approach for studying sporadic cancer in a defined mouse model.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Author notes
- Hein te Riele
Present address: Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam
Authors and Affiliations
- Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam
Marc Vooijs, Martin van der Valk, Hein te Riele & Anton Berns
Authors
- Marc Vooijs
- Martin van der Valk
- Hein te Riele
- Anton Berns
Rights and permissions
About this article
Cite this article
Vooijs, M., van der Valk, M., Riele, H. et al. Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse.Oncogene 17, 1–12 (1998). https://doi.org/10.1038/sj.onc.1202169
- Received: 23 February 1998
- Accepted: 03 June 1998
- Published: 14 July 1998
- Issue date: 09 July 1998
- DOI: https://doi.org/10.1038/sj.onc.1202169